Ameriprise
OLMA icon

Ameriprise’s Olema Pharmaceuticals OLMA Stock Holding History

Ameriprise’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$855K Sell
57,362
-147,267
-72% -$3.28M ﹤0.01% 3374
2025
Q4 		$5.12M Sell
204,629
-942,439
-82% -$16.8M ﹤0.01% 2416
2025
Q3 		$11.2M Sell
1,147,068
-25,795
-2% -$155K ﹤0.01% 1832
2025
Q2 		$5M Buy
1,172,863
+773,064
+193% +$3.45M ﹤0.01% 2361
2025
Q1 		$1.5M Sell
399,799
-49,899
-11% -$251K ﹤0.01% 3040
2024
Q4 		$2.62M Sell
449,698
-13,426
-3% -$134K ﹤0.01% 2773
2024
Q3 		$5.53M Buy
463,124
+22,058
+5% +$282K ﹤0.01% 2299
2024
Q2 		$4.77M Buy
441,066
+127,820
+41% +$1.39M ﹤0.01% 2350
2024
Q1 		$3.55M Buy
313,246
+52,889
+20% +$682K ﹤0.01% 2574
2023
Q4 		$3.65M Sell
260,357
-88,918
-25% -$1.19M ﹤0.01% 2558
2023
Q3 		$4.31M Buy
349,275
+119,910
+52% +$1.22M ﹤0.01% 2395
2023
Q2 		$2.07M Buy
+229,365
New +$1.38M ﹤0.01% 2850
2021
Q4 		– Sell
-210,926
Closed -$5.82M – 4025
2021
Q3 		$5.82M Sell
210,926
-311,148
-60% -$8.4M ﹤0.01% 2281
2021
Q2 		$14.6M Buy
522,074
+57,060
+12% +$1.62M ﹤0.01% 1602
2021
Q1 		$15.4M Buy
465,014
+98,412
+27% +$4.22M 0.01% 1533
2020
Q4 		$17.6M Buy
+366,602
New +$17.2M 0.01% 1316

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Ameriprise's OLMA Position: Q1 2026 in Review

Ameriprise reduced its Olema Pharmaceuticals (OLMA) stake by 72% in Q1 2026, selling an estimated $3.28M and leaving 57,362 shares worth $855K. The position accounts for ﹤0.01% of the portfolio, ranked #3374.

Ameriprise first reported a position in OLMA in Q4 2020 and has held it in 16 quarters since. The position peaked at $17.6M in Q4 2020. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Ameriprise held 57,362 shares of Olema Pharmaceuticals worth $855K as of Q1 2026.
  • Ameriprise sold 147,267 Olema Pharmaceuticals shares in Q1 2026, an estimated $3.28M.
  • Olema Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3374 holding.
  • Ameriprise first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
  • Ameriprise's Olema Pharmaceuticals position peaked at $17.6M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.